Cancer Treatment Reviews
Volume 31, Issue 7 , Pages 577-581 , November 2005

Adding temozolomide to radiotherapy prolongs survival in people with glioblastoma: Abstracted from: Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987–96.

References 

  1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:1030
  2. McCarthy BJ, Kruchko C. Consensus conference on cancer registration of brain and central nervous system tumors. Neuro-oncology. 2005;7:196201
  3. Brandes AA. State-of-the-art treatment of high-grade brain tumors. Semin Oncol. 2003;30(Suppl. 19):49
  4. Lonardi S, Tosoni A, Brandes AA. Adjuvant chemotherapy in the treatment of high grade gliomas. Cancer Treat Rev. 2005;31:7989
  5. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:98796
  6. Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352:9971003

☆ Sources of funding: Supported by grants from the National Cancer Institute and Schering-Plough, Kenilworth, NJ.

☆☆ For correspondence: Dr. Stupp, Multidisciplinary Oncology Center, Centre Hospitalier Universitaire Vaudois, 46 rue du Bugnon, CH-1011 Lausanne, Switzerland. E-mail: roger.stupp@chuv.hospvd.ch

☆☆☆ Abstract provided by Bazian Ltd., London.

PII: S0305-7372(05)00135-0

doi: 10.1016/j.ctrv.2005.08.004

Cancer Treatment Reviews
Volume 31, Issue 7 , Pages 577-581 , November 2005

Article Tools